Tivozanib plus nivolumab versus tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor: results of the phase 3 TiNivo-2 Study.
Tivozanib 加 nivolumab 與 tivozanib 單藥治療在接受免疫檢查點抑制劑後的腎細胞癌患者中的比較:第 3 期 TiNivo-2 研究結果。
Lancet 2024-09-16
First-Line Selpercatinib or Chemotherapy and Pembrolizumab in <i>RET</i> Fusion-Positive NSCLC.
<i>RET</i>融合陽性非小細胞肺癌的一線治療:Selpercatinib或化療和Pembrolizumab。
N Engl J Med 2024-03-30
Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non-small cell lung cancer (NSCLC) through inhibition of HIF-1α.
Canagliflozin單獨或與放射線治療結合在非小細胞肺癌(NSCLC)中通過抑制HIF-1α介導腫瘤抑制。
Mol Oncol 2023-11-04
Clear Cell Renal Cell Carcinoma: A Comprehensive in silico Study in Searching for Therapeutic Targets.
清除細胞腎細胞癌:全面的體外研究尋找治療靶點。
Kidney Blood Press Res 2024-04-12